Page last updated: 2024-11-01

omeprazole and Secondary Hyperparathyroidism

omeprazole has been researched along with Secondary Hyperparathyroidism in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research Excerpts

ExcerptRelevanceReference
" The patient was also treated with omeprazole (20 mg/day) because of chronic gastritis."3.73Gastric pH, sevelamer hydrochloride and omeprazole. ( Capitanini, A; Del Corso, C; Gallieni, M; Lupi, A; Osteri, F; Petrone, I; Rossi, A; Straniti, M, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capitanini, A1
Lupi, A1
Osteri, F1
Petrone, I1
Del Corso, C1
Straniti, M1
Gallieni, M1
Rossi, A1

Other Studies

1 other study available for omeprazole and Secondary Hyperparathyroidism

ArticleYear
Gastric pH, sevelamer hydrochloride and omeprazole.
    Clinical nephrology, 2005, Volume: 64, Issue:4

    Topics: Adult; Anti-Ulcer Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Interactions; Fema

2005